Hot Features
プレミアム
Monte Rosa Therapeutics Inc (GLUE)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enable... Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enables to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates. 詳細を表示
BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines...
MRT-6160, a potent and highly selective VAV1-directed molecular glue degrader, represents a potential novel therapeutic approach for systemic and neurological autoimmune and inflammatory diseases...
IND clearance achieved for MRT-6160, a VAV1-directed MGD in development for systemic and neurological autoimmune diseases; on track to initiate Phase 1 SAD/MAD study this summer with initial...
BOSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines...
Ongoing Phase 1/2 Study of MRT-2359 for MYC-driven solid tumors demonstrates favorable safety and pharmacodynamic profile dosing 0.5 mg using a 21/7 schedule; currently assessing 0.75 mg dose...
MRT-6160, a VAV1-directed molecular glue degrader (MGD), inhibits disease progression, pro-inflammatory cytokines and autoantibody production in a model of rheumatoid arthritis Initiation of...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.34 | -6.26151012891 | 5.43 | 5.55 | 4.9202 | 234900 | 5.28376716 | CS |
| 4 | -0.92 | -15.3078202995 | 6.01 | 6.84 | 4.9202 | 395944 | 6.03785886 | CS |
| 12 | 0.92 | 22.0623501199 | 4.17 | 7.08 | 3.52 | 275446 | 5.54957863 | CS |
| 26 | -1.99 | -28.1073446328 | 7.08 | 8.22 | 3.21 | 242627 | 5.09680398 | CS |
| 52 | 0.66 | 14.8984198646 | 4.43 | 8.84 | 2.44 | 236099 | 4.89517 | CS |
| 156 | -15 | -74.6640119462 | 20.09 | 27.565 | 2.44 | 207483 | 8.14400403 | CS |
| 260 | -16.91 | -76.8636363636 | 22 | 45.56 | 2.44 | 214744 | 10.29843857 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
